The correct name of diphosphocholine is cytarabine, which can promote glucose uptake in the brain, can increase cerebral blood flow, improve cerebral circulation, used for traumatic brain injury or cerebral hemorrhage triggered by impaired consciousness; it can inhibit the activity of lecithinase, but also can promote the synthesis of lecithin, and promote the recovery of the function of pancreas, which can be used for acute pancreatitis or recurrent chronic pancreatitis in acute episodes. Cytarabine can lead to adverse reactions such as rash, insomnia, numbness of limbs, nausea and dizziness, loss of appetite, decreased blood pressure, respiratory distress, etc., which can lead to shock in severe cases. Note that the person who is allergic to this product is prohibited. When injecting this product intramuscularly, attention should be paid to the fact that it should not be injected repeatedly at the same site. Patients must use the drug under the guidance of a professional physician and strictly comply with medical advice.